The increasing incidence of obesity and diabetes implores a need to better understand neurobiological and physiological mechanisms regulating energy balance and glucose metabolism. Acute activation of neuropeptide Y/Agouti-related peptide (NPY/AgRP)--expressing neurons restricted to the arcuate (ARC) nucleus of hypothalamus evokes voracious feeding while concomitantly impairing energy expenditure and glucose homeostasis \[[@B1]\]. Conversely, inhibition of NPY/AgRP neuronal activity rapidly suppresses feeding behavior \[[@B3], [@B5]\]. Several circulating factors including leptin and insulin have been suggested to suppress the acute activity of NPY/AgRP neurons. The inhibitory effects of leptin and insulin in NPY/AgRP neurons have been directly associated with that of phosphoinositide 3-kinase (PI3K) \[[@B6]\]. Thus, a cellular mechanism of leptin and insulin action within the brain to regulate energy balance and glucose homeostasis has been proposed to require at least in part PI3K activity in NPY/AgRP neurons \[[@B8], [@B12], [@B13]\].

PI3Ks act in the hypothalamus as dimers of a catalytic subunit (p110*α* or p110*β*) and a p85 regulatory subunit \[[@B14]\]. Interestingly, p110*β* appears to have a dominant role in NPY/AgRP neurons, as mice deficient for p110*β* in AgRP neurons are lean and display hypoleptinemia. However, selective deletion of either p110*α* or p110*β* catalytic subunits alone in NPY/AgRP neurons fails to alter fasting glucose levels, glucose tolerance, or fasting insulin levels \[[@B8]\]. Moreover, deficiency of either p110*α* or p110*β* in NPY/AgRP neurons alone fails to diminish the acute cognate effects of leptin and insulin in NPY/AgRP neurons \[[@B8]\]. Importantly, the presence of one p110 isoform may be sufficient to compensate for the loss of the other, providing evidence for a functional redundancy of p110 isoforms in various tissues \[[@B15], [@B16]\]. As a result, deletion of both p110*α* and p110*β* isoforms may provide a more direct test of the PI3K dependence of leptin and insulin responses in NPY/AgRP neurons as well as PI3K activity on metabolism. In the current study, the hypothesis that both p110*α* and p110*β* are required for the acute inhibition of NPY/AgRP neurons by leptin and insulin was tested using whole-cell recordings in hypothalamic slices from mice. Acute effects of leptin and insulin were assessed on intrinsic membrane properties of NPY/AgRP neurons, including subsets of leptin receptor (LepR)--positive and --negative NPY neurons. The requirement of p110*α* and p110*β* in AgRP neurons to regulate energy balance and glucose homeostasis was also assessed. Together, these data provide a possible cellular mechanism in which PI3K regulates energy balance and glucose homeostasis via NPY/AgRP neuronal activity.

1. Materials and Methods {#s1}
========================

A. Animals {#s2}
----------

Male mice were used for all experiments. All mice were housed under standard laboratory conditions (12 hours on/off; lights on at 7:00 [am]{.smallcaps}) and temperature-controlled environment with food and water available *ad libitum*. All experiments were performed in accordance with the guidelines established by the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by The University of Texas Institutional Animal Care and Use Committee. Mice were provided a Harlan Teklad 2016 chow diet or high-fat/high-sucrose (D12331; Research Diets) diet and water *ad libitum* unless otherwise noted. Mice that incurred a 10% body weight loss during the acclimation period for metabolic cage studies (described later) were not used. Body weight was measured weekly and body composition was measured by using nuclear magnetic resonance (Bruker minispec; Bruker Corporation).

To identify NPY neurons with or without LepRs, we generated NPY-hrGFP::LepR-cre::tdTomato (NLT) mice as previously described \[[@B17]\], anatomically restricted to the ARC nucleus of the hypothalamus. Briefly, LepR reporter mice were made by mating LepR-cre mice \[[@B18]\] with the tdTomato reporter mouse (\#007908; The Jackson Laboratory). LepR-cre::tdTomato reporter mice were subsequently mated with NPY-humanized Renilla green fluorescent protein (hrGFP) mice \[[@B19]\] to produce NPY-hrGFP::LepR-cre::tdTomato (NLT) mice. For inactivation of both p110*α* and p110*β* on AgRP neurons, we crossed mice carrying a conditional mutation in the PI3K catalytic subunits Pik3ca (p110*α*) and Pik3cb (p110*β*) \[[@B20], [@B21]\] with transgenic mice expressing cre driven by the AgRP promoter \[[@B22]\], followed by interbreeding with tdTomato mice \[AgRP-cre::p110*α*^fl/fl^::p110*β*^fl/fl^::tdTomato (APT)\]. A separate cohort of mice were generated that were deficient for both LepR and insulin receptor (InsR) in AgRP neurons by breeding AgRP-cre mice with mice containing a conditional mutation in the LepR and InsR \[[@B23], [@B24]\]. These mice were then crossed with tdTomato mice (AgRP-cre::LepR^fl/fl^::InsR ^fl/fl^::tdTomato).

B. Metabolic Chambers {#s3}
---------------------

Experiments were performed in a temperature-controlled room containing 36 TSE Systems metabolic cages maintained by The University of Texas Southwestern Animal Resources personnel. One week prior to the study, mice were singly housed to acclimate to new housing. Three days prior to the study, mice were transported to the room containing the metabolic cages to acclimate to a new environment. A high-fat/high-sucrose diet, if applicable, was also introduced at the beginning of this acclimation period. After 3 days' acclimation, cages were connected to the TSE Systems for a total of 5 days. Days 2 to 4 were used for data analyses.

C. Glucose Tolerance Tests {#s4}
--------------------------

After an overnight fast, 10- to 14-week-old male mice received IP injections of 1.5 g/kg [d]{.smallcaps}-glucose. Blood glucose was measured from tail blood using a glucometer at serial time points as indicated in the figures.

D. Insulin Tolerance Tests {#s5}
--------------------------

After a 4-hour fast to empty the stomach, 10- to 14-week-old male mice received IP injections of insulin (1.2 units/kg). Blood glucose was measured from tail blood as described previously.

E. Pyruvate Tolerance Tests {#s6}
---------------------------

After a 6-hour fast to empty the stomach, 10- to 14-week-old male mice received IP injections of 2 mg/kg pyruvate. Blood glucose was measured from tail blood as described previously.

F. Analysis of Gene Expression by Quantitative PCR {#s7}
--------------------------------------------------

Total RNA was extracted from tissues with TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Total RNA (1 mg) was converted into first-strand cDNA with oligo(dT) primers as described by the manufacturer (Clontech). PCR was performed in an Mx3000P Q-PCR system (Stratagene) with specific primers and SYBR Green PCR Master Mix (Stratagene). The relative abundance of mRNAs was standardized with 18S mRNA as the invariant control.

G. Electrophysiology Studies {#s8}
----------------------------

Brain slices were prepared from young adult male mice (6 to 12 weeks old) as previously described \[[@B25], [@B26]\]. Briefly, male mice were deeply anesthetized with an IP injection of 7% chloral hydrate and transcardially perfused with a modified ice-cold artificial cerebrospinal fluid (ACSF; described later). The mice were then decapitated, and the entire brain was removed and immediately submerged in ice-cold, carbogen-saturated (95% O~2~ and 5% CO~2~) ACSF (126 mM NaCl, 2.8 mM KCl, 1.2 mM MgCl~2~, 2.5 mM CaCl~2~, 1.25 mM NaH~2~PO~4~, 26 mM NaHCO~3~, and 5 mM glucose). Coronal sections (250 μm) were cut with a VT1000S Vibratome (Leica Microsystems) and then incubated in oxygenated ACSF at room temperature for at least 1 hour before recording. The slices were bathed in oxygenated ACSF (32°C to 34°C) at a flow rate of \~2 mL/min. All electrophysiology recordings were performed at room temperature.

The pipette solution for whole-cell recording was modified to include an intracellular dye (Alexa Fluor 350 hydrazide dye) for whole-cell recording: 120 mM K-gluconate, 10 mM KCl, 10 mM HEPES, 5 mM EGTA, 1 mM CaCl~2~, 1 mM MgCl~2~, 2 mM ATP, and 0.03 mM Alexa Fluor 350 hydrazide dye (pH 7.3). Epifluorescence was briefly used to target fluorescent cells, at which time the light source was switched to infrared differential interference contrast imaging to obtain the whole-cell recording \[Axioskop FS2 Plus equipped with a fixed stage (Zeiss) and a QuantEM:512SC electron-multiplying charge-coupled device camera (Photometrics)\]. Electrophysiological signals were recorded using an Axonpatch 700B amplifier (Molecular Devices), low-pass filtered at 2 to 5 kHz, and analyzed offline on a personal computer with pCLAMP programs (Molecular Devices). Membrane potential and firing rate were measured by whole-cell current clamp recordings from NPY/AgRP neurons in brain slices. Recording electrodes had resistances of 2.5 to 5 MΩ when filled with the K-gluconate internal solution. Input resistance was assessed by measuring voltage deflection at the end of the response to hyperpolarizing rectangular current pulse steps (500 ms of −10 to −50 pA).

Solutions containing drugs were typically perfused for 5 minutes. A drug effect was required to be associated temporally with peptide application, and the response had to be stable within a few minutes. A neuron was considered depolarized or hyperpolarized if a change in membrane potential was at least 2 mV in amplitude.

H. Drugs {#s9}
--------

Leptin (100 nM; provided by A. F. Parlow through the National Hormone and Peptide Program), Humulin (50 nM; Eli Lilly and Company), tolbutamide (200 μM; Sigma-Aldrich), tetrodotoxin (TTX; 2 μM; Tocris Bioscience), LY294002 (10 µM; Calbiochem), wortmannin (100 nM; Tocris Bioscience), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 μM; Sigma-Aldrich), AP5 (50 μM; Sigma-Aldrich), and picrotoxin (50 μM; Sigma-Aldrich) were added to the ACSF for specific experiments. All solutions were made according to the manufacturer's specifications. Stock solutions of LY294002, wortmannin, CNQX, and picrotoxin were made by dissolution in dimethyl sulfoxide (Sigma-Aldrich). The concentration of dimethyl sulfoxide in the external solution was \<0.1%. Stock solutions of leptin were made by dissolution in Dulbecco's PBS (Gibco). Stock solutions of TTX and AP5 were made by dissolution in deionized water.

I. Cell Counting {#s10}
----------------

Cell counts of LepR- and NPY-expressing ARC neurons were performed as previously described \[[@B27]\]. Briefly, the male NLT mice (n = 6; male) were anesthetized, transcardially perfused with the 0.95% saline for 1 minute, and then shift to the 10% neural buffered formalin for 6 to 8 minutes. The mice were then decapitated, and the entire brain was removed, fixed by 10% neural buffered formalin for 4 hours at room temperature, and cryopreserved in 30% sucrose at 4°C overnight. Brains were then sectioned into 25-μm coronal sections and separated equally into five series. The slices were stored in cryoprotectant at −20°C until use. Counts of GFP- and tdTomato-labeled cells were made using ImageJ software (National Institutes of Health) by an observer who was blinded to the condition or genotype of the mice with the aid of a Zeiss microscope. Sections that come from two series were viewed at 10 magnifications, and the number of reporters labeled cells was quantified in the retrochiasmatic area and ARC. Counts from the retrochiasmatic area and ARC were obtained from maximal rostrocaudal area of each brain (n = 6), corresponding to the planes from 0.94 mm to 2.80 mm posterior to bregma in the Paxinos and Franklin atlas \[[@B30]\].

J. Analysis and Statistics {#s11}
--------------------------

Results are reported as the mean ± SEM unless indicated otherwise, in which n represents the number of cells studied. Significance was set at *P* \< 0.05 for all statistical measures.

2. Results {#s12}
==========

A. AgRP-Specific Disruption of Both p110*α* and p110*β* Exacerbates Body Weight Gain {#s13}
------------------------------------------------------------------------------------

To determine the requirement of both p110*α* and p110*β* in AgRP neurons for the maintenance of energy homeostasis, we monitored metabolic parameters in mice with p110*α* and p110*β* double deficiency (AgRP-cre::p110*α*^fl/fl^::p110*β*^fl/fl^) on a chow diet. Deletion of p110*α* and p110*β* in ARC AgRP neurons was validated in study subjects ([Supplemental Fig. 1](#sup1){ref-type="supplementary-material"}). Mice deficient for both p110*α* and p110*β* in AgRP neurons displayed an age-dependent increase in body weight concurrent with increased fat and lean mass (\**P* \< 0.05; [Fig. 1A and 1B](#F1){ref-type="fig"}). When compared with their control littermates, mice deficient for p110*α* and p110*β* in AgRP neurons displayed decreased energy expenditure independent of changes in food intake or activity levels ([Fig. 1C--1F](#F1){ref-type="fig"}), supporting a requirement of both p110*α* and p110*β* AgRP neurons for the proper regulation of energy balance. Similar results were obtained when mice were placed on a high-fat diet ([Supplemental Fig. 2A](#sup1){ref-type="supplementary-material"}).

![AgRP-specific disruption of both p110*α* and p110*β* exacerbates body weight gain and suppresses energy expenditure. (A) Body weight curve of male AgRP-cre::p110*α*^fl/fl^::p110*β*^fl/fl^ mice on a chow diet. (B) Body composition of male AgRP-cre::p110*α*^fl/fl^::p110*β*^fl/fl^ mice on a chow diet. (C) Double deletion of p110*α* and p110*β* in AgRP neurons does not affect food intake (FI). AgRP-specific disruption for both p110*α* and p110*β* suppresses (D) oxygen uptake (VO~2~), (E) carbon dioxide production (VCO~2~), and (F) heat production (10 weeks). Error bars indicate SEM. \**P* \< 0.05.](js.2018-00061f1){#F1}

B. Inactivation of Both p110*α* and p110*β* in AgRP Neurons Impairs Glucose and Insulin Sensitivity {#s14}
---------------------------------------------------------------------------------------------------

In addition to impairments of energy homeostasis, simultaneous p110*α* and p110*β* deficiency in AgRP neurons induced systemic glucose intolerance and insulin resistance independent of diet ([Fig. 2A and 2B](#F2){ref-type="fig"}; [Supplemental Fig. 2B and 2C](#sup1){ref-type="supplementary-material"}). Moreover, when pyruvate was provided as a fuel source, AgRP-cre::p110*α*^fl/fl^::p110*β*^fl/fl^ mice produced higher levels of glucose compared with littermate controls ([Fig. 2C](#F2){ref-type="fig"}). We next considered the effects on glucose production in the liver by using quantitative real-time quantitative reverse transcription polymerase chain reaction to examine genes within the liver that play a role in gluconeogenesis. AgRP-specific deletion of p110*α* and p110*β* showed increased mRNA levels of *Foxo1, G6pc, HNF4α, pcx,* and *pepck* in the liver ([Fig. 2D](#F2){ref-type="fig"}), supporting a role for AgRP-specific deletion of p110*α* and p110*β* to enhance hepatic glucose production.

![Inactivation of both p110*α* and p110*β* in AgRP neurons impairs glycemia and insulin sensitivity. Inactivation of both p110*α* and p110*β* in AgRP neurons impairs (A) glucose tolerance and (B) insulin sensitivity and (C) increases hepatic glucose production. (D) AgRP-specific deletion of p110*α* and p110*β* increases mRNA levels of *Foxo1, G6pc, HNF4α, pcx,* and *pepck*. Error bars indicate SEM. \**P* \< 0.05.](js.2018-00061f2){#F2}

C. The Leptin-Induced Hyperpolarization of LepR-Positive NPY Neurons Requires Both p110*α* and p110*β* {#s15}
------------------------------------------------------------------------------------------------------

The distribution of ARC NPY/AgRP neurons that express or do not express LepRs was mapped from NLT mice. We found 64.1% of NPY-hrGFP neurons restricted to the ARC nucleus were positive for LepRs, whereas 52.4% of LepR-positive ARC neurons also expressed NPY-hrGFP ([Supplemental Table 1](#sup2){ref-type="supplementary-material"} and [Supplemental Fig. 3](#sup1){ref-type="supplementary-material"}). Both LepR-positive and -negative ARC NPY/AgRP neurons were targeted for electrophysiological recordings. Real-time visualization under fluorescence microscopy and Alexa Fluor 350 hydrazide dye was used to dialyze neurons recorded ([Fig. 3A--3E](#F3){ref-type="fig"}). Consistent with the previous reports \[[@B7], [@B31]\], a majority of LepR-positive NPY-hrGFP neurons were hyperpolarized by local administration of leptin \[100 nM; 79%; change in resting membrane potential (RMP): −9.9 ± 1.2 mV; resting membrane potential: −44.7 ± 1.1 mV; n = 30; [Fig. 3F](#F3){ref-type="fig"}\]. The remaining neurons failed to respond to leptin (change in RMP: −0.5 ± 0.4 mV; resting membrane potential: −43.2 ± 1.9 mV; n = 8; data not shown). The hyperpolarization induced by leptin (100 nm) was also observed in the presence of TTX (2 μm; 72%, change in RMP: −10.1 ± 2.1 mV; resting membrane potential: −42.7 ± 1.9 mV; n = 11; data not shown), indicative of a direct membrane hyperpolarization independent of action potential--mediated synaptic transmission. Additionally, application of leptin on LepR-positive NPY-hrGFP neurons reduced the firing frequency concomitant with a decrease in input resistance (25%; 1600 ± 53 MΩ for control, 1200 ± 101 MΩ for leptin; reversal potential of −90 ± 2.3 mV; n = 8; [Fig. 3G and 3H](#F3){ref-type="fig"}). Subsequent application of tolbutamide (200 μM) following leptin administration completely reversed the hyperpolarization of LepR-positive NPY-hrGFP neurons induced by leptin (n = 12) ([Fig. 3I](#F3){ref-type="fig"}). All LepR-negative NPY-hrGFP neurons tested were unresponsive to leptin (change in RMP: −0.6 ± 1.4 mV; n = 13; [Fig. 3J](#F3){ref-type="fig"}). Moreover, AgRP neurons deficient for LepRs (AgRP-cre::LepR-flox::tdTomato) failed to respond to leptin (change in RMP: −0.3 ± 0.3 mV; n = 10; [Supplemental Fig. 4](#sup1){ref-type="supplementary-material"}). Collectively, these data support a leptin-induced hyperpolarization of LepR-positive NPY-hrGFP neurons that is dependent upon activation of an ATP-sensitive K^+^ (K~ATP~) channel.

![The leptin-induced hyperpolarization of LepR-positive NPY neurons requires both p110*α* and p110*β* catalytic subunits. (A) Bright-field illumination of NPY-hrGFP::LepR-cre::tdTomato neuron from NLT mice. (B) and (C) show the same neuron under fluorescein isothiocyanate (FITC; hrGFP) and Alexa Fluor 594 (tdTomato) illumination. Complete dialysis of Alexa Fluor 350 from the intracellular pipette is shown in (D) and (E) the merged image of targeted NPY neuron (arrow indicates the targeted cell). Scale bar, 50 µm. (F) Electrophysiological study demonstrates an NPY-hrGFP::Lepr-cre::tdTomato (green/red) neuron that was hyperpolarized in response to leptin. (G) Leptin administration decreases input resistance of NPY-hrGFP::Lepr-cre::tdTomato (green/red) neuron. (H) I-V relationship of one NPY-hrGFP::Lepr-cre::tdTomato (green/red) neuron in response to leptin. (I) Administration of tolbutamide reverses the leptin-induced hyperpolarization of an NPY-hrGFP::Lepr-cre::tdTomato (green/red) neuron. (J) Leptin failed to affect the cellular activity of LepR-negative NPY (green) neurons. (K) Current-clamp recording demonstrates that pretreatment NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons with wortmannin diminished the leptin-induced hyperpolarization. (L) Pretreatment with LY294002 abolishes leptin-induced hyperpolarization of NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons. (M) Double deletion of p110*α* and p110*β* in AgRP neurons disrupts the leptin-induced hyperpolarization. (N) Histogram summarizes the leptin-induced change of membrane potential of NPY neurons from NLT mice with wortmannin and LY294002 treatment as well as AgRP neurons from APT mice. Error bars indicate SEM. \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001.](js.2018-00061f3){#F3}

To determine the involvement of PI3K in mediating leptin-induced hyperpolarization of NPY neurons, we introduced PI3K antagonists wortmannin and LY294002 to brain slices containing the ARC followed by application of leptin. Pretreatment with wortmannin (100 nM; 10 minutes) blocked the leptin-induced hyperpolarization of LepR-positive NPY-hrGFP neurons (−0.7 ± 1.3 mV; resting membrane potential: −43.8 ± 0.9; n = 13; [Fig. 3K](#F3){ref-type="fig"}). Similarly, in the presence of LY294002 (10 μM; 10 minutes), leptin failed to hyperpolarize all LepR-positive NPY-hrGFP neurons (−0.3 ± 1.6 mV; resting membrane potential: −44.1 ± 1.6 mV; n = 11; [Fig. 3L](#F3){ref-type="fig"}). The requirement of PI3K signaling in the leptin-induced hyperpolarization of NPY/AgRP neurons was then assessed in AgRP neurons deficient for both p110*α* and p110*β*. The inactivation of both subunits did not lead to observable alterations in AgRP whole-cell conductance (commonly used as a measure of cell size) \[[@B32]\], nor were the resting membrane potential, basal firing rate, and whole-cell input resistance altered ([Supplemental Fig. 5](#sup1){ref-type="supplementary-material"}). Notably, in AgRP neurons with double deletion of p110*α* and p110*β*, leptin failed to induce a change in the membrane potential (−0.5 ± 0.4 mV; resting membrane potential: −41.3 ± 1.6 mV; n = 14; [Fig. 3M](#F3){ref-type="fig"}). Taken together, these data suggest that both p110*α* and p110*β* subunits are required for the leptin-induced hyperpolarization of AgRP neurons ([Fig. 3N](#F3){ref-type="fig"}).

D. Insulin Hyperpolarized NPY Neurons Rely on Both p110*α* and p110*β* {#s16}
----------------------------------------------------------------------

To assess the acute effects of insulin, both LepR-positive and -negative ARC NPY/AgRP neurons were targeted for electrophysiological recordings. Interestingly, \~94.4% of LepR-positive NPY-hrGFP neurons were hyperpolarized by insulin administration (50 nM; change in RMP: −17.4 ± 3.8 mV; resting membrane potential: −43.8 ± 1.4 mV; n = 17; [Fig. 4A](#F4){ref-type="fig"}). Analogous to the results of leptin, we found that the insulin-induced hyperpolarization persisted after pretreatment of NPY-hrGFP neurons with 2 μM TTX followed by application of insulin (80%; change in RMP: −12.1 ± 3.1 mV; resting membrane potential: −43.7 ± 1.2 mV; n = 10; data not shown), supporting a direct membrane hyperpolarization of NPY neurons by insulin independent of action potential--mediated synaptic transmission. The insulin-induced hyperpolarization was accompanied by a decrease in the firing frequency and input resistance (33.3%; 1520 ± 80 MΩ for control, 1110 ± 110 MΩ for insulin; reversal membrane potential crossed at −90 ± 3.8 mV; n = 8; [Fig. 4B and 4C](#F4){ref-type="fig"}). Notably, 94% of LepR-negative NPY-hrGFP neurons from the same mice were also hyperpolarized by insulin administration (change in RMP: −10.9 ± 2.4 mV; resting membrane potential: −41.3 ± 2.2 mV; n = 16; [Fig. 4E](#F4){ref-type="fig"}). AgRP neurons deficient for InsRs (AgRP-cre::InsR-flox::tdTomato) failed to respond to insulin (change in RMP: −0.5 ± 0.3 mV; n = 15; [Supplemental Fig. 4](#sup1){ref-type="supplementary-material"}), supporting a requirement of InsRs in the acute change of cellular activity. The insulin-induced hyperpolarization of NPY-hrGFP neurons (both LepR-positive and -negative) was completely rescued after administration of tolbutamide (200 μM; n = 11; [Fig. 4D](#F4){ref-type="fig"}), suggesting insulin can exert its acute inhibitory effects via activation of a K~ATP~ channel. To examine the requirement of PI3K signaling in the insulin-induced inhibition of NPY/AgRP, brain slices containing the ARC nucleus were pretreated with PI3K antagonists, wortmannin, and LY294002. The PI3K antagonists (100 nM wortmannin and 10 µM LY294002) abrogated the insulin-induced hyperpolarization of LepR-positive and -negative NPY-hrGFP neurons (wortmannin, change in RMP: −0.2 ± 1.3 mV; resting membrane potential: −44.4 ± 0.9 mV; n = 11, [Fig. 4F](#F4){ref-type="fig"}; LY294002: change in RMP: −0.7 ± 1.6 mV; resting membrane potential: −45.1 ± 1.6 mV; n = 11; [Fig. 4G](#F4){ref-type="fig"}). Interestingly, insulin also failed to hyperpolarize all AgRP neurons deficient for p110*α* and p110*β* ([Fig. 4H](#F4){ref-type="fig"}). Collectively, these data suggest a mechanism in which both p110*α* and p110*β* subunits are necessary for the insulin-induced hyperpolarization of AgRP neurons ([Fig. 4I](#F4){ref-type="fig"}).

![The insulin-induced hyperpolarization of NPY/AgRP neurons requires both p110*α* and p110*β* catalytic subunits. (A) Representative electrophysiological trace illustrates an NPY-hrGFP::Lepr-cre::tdTomato (green/red) neuron is hyperpolarized by insulin. (B) Insulin administration decreased input resistance of NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons. (C) I-V relationship of NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons in response to insulin. (D) Administration of tolbutamide rescues the hyperpolarization of NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons induced by insulin. (E) Current-clamp recording illustrating that insulin administration also hyperpolarized a LepR-negative NPY (green) neuron. (F) Representative electrophysiological trace shows that pretreatment NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons with (100 nM) wortmannin blocks insulin-induced hyperpolarization. (G) Insulin fails to hyperpolarize NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons when pretreated with (10 µM) LY294002. (H) AgRP-specific deletion of both p110*α* and p110*β* abrogated the insulin-induced hyperpolarization. (I) Histogram illustrates the insulin-induced change of membrane potential of NPY neurons from NLT mice with wortmannin and LY294002 treatment as well as AgRP neurons from APT mice. Error bars indicate SEM. \*\**P* \< 0.01; \*\*\**P* \< 0.001.](js.2018-00061f4){#F4}

E. AgRP-Specific Disruption of Both p110*α* and p110*β* Fails to Abrogate Activation of NPY/AgRP Neurons by Ghrelin {#s17}
-------------------------------------------------------------------------------------------------------------------

The acute effects of ghrelin were examined in NPY-hrGFP neurons that express and do not express LepRs. Notably, 7 out of 12 LepR-positive NPY-hrGFP neurons were depolarized by ghrelin administration, with a reversal membrane potential crossed at −25.8 ± 4.5 mV (58%; 5.3 ± 0.8 mV; resting membrane potential: −41.5 ± 1.1 mV; n = 7; [Fig. 5A and 5C](#F5){ref-type="fig"}). A similar percentage of LepR-negative NPY-hrGFP neurons were activated in response to ghrelin (60%; change in RMP: 6.1 ± 1.1 mV; resting membrane potential: −41.1 ± 1.7 mV; n = 5; [Fig. 5B](#F5){ref-type="fig"}). Pretreatment of NPY-hrGFP neurons with TTX and synaptic blockers failed to blunt the stimulatory effect of ghrelin (6.4 ± 1.2 mV; [Fig. 5D](#F5){ref-type="fig"}), supporting a postsynaptic site of action. Additionally, a subset (n = 7) of LepR-positive NPY-hrGFP neurons were recorded in voltage clamp under normal recording conditions at a membrane potential of −70 mV, and application of ghrelin resulted in an inward current in four out of seven neurons (−23.4 ± 2.1 pA; n = 4; [Fig. 5D](#F5){ref-type="fig"}). Previous reports suggest ghrelin stimulates NPY/AgRP neurons independent of PI3K signaling \[[@B33], [@B34]\]. Accordingly, AgRP neurons deficient for both p110*α* and p110*β* were responsive to the excitatory effects of ghrelin ([Fig. 5E](#F5){ref-type="fig"}). Together, these data suggest that ghrelin activates NPY/AgRP neurons irrespective of LepR expression via activation of a mixed cation channel. Moreover, deletion of both p110*α* and p110*β* fails to abrogate this effect, implying that p110*α* and p110*β* deficiency in AgRP neurons results in a selective loss of PI3K-dependent changes of cellular activity, which include leptin and insulin.

![AgRP-specific disruption of both p110*α* and p110*β* fails to alter the ghrelin-induced activation of NPY/AgRP neurons. Electrophysiological trace demonstrating an (A) NPY-hrGFP::Lepr-cre::tdTomato (green/red) neuron and (B) NPY-hrGFP (green) neuron were depolarized by (100 nM) ghrelin. (C) I-V relationship of an NPY-hrGFP::Lepr-cre::tdTomato (green/red) neuron in response to ghrelin. (D) Pretreatment with (a) TTX (2 µM) and synaptic blockers (SB; CNQX, 10 µM; AP5, 50 µM; and picrotoxin, 50 µM) fails to abrogate the ghrelin-induced depolarization of NPY neurons, and (b) ghrelin application produced an inward current in the majority of NPY-hrGFP::Lepr-cre::tdTomato (green/red) neurons; holding potential is −70 mV. (E) Representative current-clamp record showing that AgRP-cre::p110*α*^fl/fl^::p110*β*^fl/fl^ neurons are depolarized by (100 nM) ghrelin. (F) Histogram illustrates that AgRP-specific disruption of both p110*α* and p110*β* fails to alter the ghrelin-induced depolarization. Error bars indicate SEM.](js.2018-00061f5){#F5}

3. Discussion {#s18}
=============

Selective deficiency of the PI3K catalytic subunits p110*α* and p110*β* in murine AgRP neurons resulted in increased body weight concomitant with decreased energy expenditure independent of changes in food intake. Loss of p110*α* and p110*β* in AgRP neurons also impaired glucose and insulin sensitivity. The cellular mechanism of leptin and insulin to elicit acute electrophysiological responses requires both p110*α* and p110*β* in NPY/AgRP neurons. Together, these data support a model in which loss of PI3K signaling in NPY/AgRP neurons abrogates the acute inhibitory actions of leptin and insulin in NPY/AgRP neurons, culminating in a positive energy balance and dysregulation of glucose metabolism.

The PI3K signaling pathway is involved in a variety of physiological processes including metabolic regulation. Pharmacological inhibition or global genetic deficiency of PI3K lowers body weight and fat mass by increasing white adipose tissue lipolysis and browning \[[@B35], [@B36]\]. Numerous physiological effects of leptin and insulin action via PI3K to regulate energy balance are suggested to involve the central nervous system \[[@B8], [@B31], [@B37], [@B38]\]. In particular, overactivation of PI3K signaling in LepR-positive cells resulted in a lean phenotype coincident with browning of white adipose tissue \[[@B32]\]. Similarly, loss of p110*α* and p110*β* in LepR-positive cells resulted in a lean phenotype associated with increased energy expenditure and thermogenesis \[[@B39]\]. Although these studies suggest regulation of PTEN by PI3K catalytic subunits with overlapping effects in metabolism, the role of NPY/AgRP neurons in this activity remains undefined. In the ARC, the catalytic PI3K subunits p110*α* and p110*β*, but not p110*δ*, are highly expressed \[[@B14]\]. Surprisingly, genetic inactivation of the p110*β* subunit in AgRP neurons resulted in a resistance to diet-induced obesity, whereas AgRP p110*α*-null mice failed to alter energy regulation \[[@B8]\]. It is important to note that studies using PI3K inhibitors, such as wortmannin or LY294002, fail to distinguish effects of specific PI3K subunits (both regulatory and catalytic). Although the use of subunit-specific conditional alleles allows for detailed investigation of PI3K signaling and functions, this strategy does not account for the complementary action and compensatory mechanism within p110*α* and p110*β* in the hypothalamus \[[@B40], [@B41]\]. To better examine the requirement of PI3K signaling in AgRP neurons to regulate energy balance and glucose homeostasis, we inactivated both p110*α* and p110*β* in AgRP neurons. AgRP neuron--specific p110*α* and p110*β* deletion decreased energy expenditure independent of changing food intake, ultimately leading to increased adiposity and lean mass. NPY/AgRP neurons and their congnate activity have been studied extensively in regulating feeding behavior \[[@B1], [@B3], [@B4], [@B42]\]. However, the current study demonstrates that loss of PI3K catalytic subunits abrogates the acute effects of leptin and insulin on the cellular activity of NPY neurons while at the same time failing to influence feeding. The lack of effect on food intake in the current study may be less surprising given that loss of LepRs in AgRP neurons increases body weight independent of altered feeding \[[@B45]\]. Similar effects were observed in mice deficient for LepRs in pro-opiomelanocortin (POMC) neurons \[[@B23]\]. Interestingly, loss of LepRs in both POMC and AgRP neurons produces hyperphagia, suggesting an important interaction between POMC and AgRP neurons in the regulation of feeding behavior by leptin. It is currently unclear if p110*α* and p110*β* is required in the leptin-dependent regulation of feeding by both POMC and AgRP neurons. However, the current study supports a p110*α*- and p110*β*-dependent regulation of energy balance in AgRP neurons independent of altered food intake.

In addition to energy homeostasis, PI3K inhibitors have been shown to elevate blood glucose levels potentially by perturbing insulin signaling \[[@B46]\]. In the central nervous system, intracerebroventricular insulin treatment activated hypothalamic InsR substrate--PI3K signaling \[[@B38]\]. The reduction of hepatic glucose production was induced by intracerebroventricular administration of insulin, which could be blocked by PI3K inhibitors \[[@B38], [@B49]\]. In the current study, deficiency of both PI3K catalytic subunits (p110*α* and p110*β*) in AgRP neurons impaired glucose and insulin sensitivity in mice. We speculate PI3K signaling in AgRP neurons might be a cellular link in the insulin-induced regulatory effect on glucose.

The acute activity of AgRP neurons has been closely linked to the regulation of energy balance and glucose homeostasis \[[@B1], [@B3], [@B4], [@B43], [@B50]\]. In particular, acute activation of AgRP neurons induced insulin resistance by inhibiting glucose uptake of brown adipose tissue \[[@B4]\]. Interestingly, the metabolic effectors leptin and insulin suppress the activity of AgRP neurons \[[@B6], [@B8], [@B9], [@B31], [@B51]\]. In the current study, the inhibitory effect of leptin required both LepRs and K~ATP~ channels. Additionally, inactivation of PI3K signaling via concurrent deficiency of p110*α* and p110*β* blunted the leptin-induced hyperpolarization in AgRP neurons. Similar to leptin, insulin also inhibited the activity of AgRP neurons via an InsR-dependent activation of PI3K catalytic subunits (p110*α* and p110*β*) and a downstream K~ATP~ channel. However, it is important to note that electrophysiological assessments of the circulating factors: leptin and insulin on NPY/AgRP neurons has been somewhat controversial. In agreement with several previous reports, in the current study, both leptin and insulin inhibit NPY/AgRP neurons \[[@B6], [@B31], [@B51], [@B52]\]. Notably, we failed to detect activation of any NPY/AgRP neurons recorded in response to either leptin or insulin; however, a few studies show no effect or a stimulatory activity of these compounds on NPY/AgRP neurons \[[@B8], [@B53]\]. Additionally, a recent report failed to detect changes in NPY/AgRP-specific calcium dynamics *in vivo* in response to several peripherally administered compounds, including leptin \[[@B54]\]. A possible explanation for these conflicting results might be due to the fact that approximately one-half of NPY-hrGFP neurons in ARC nucleus express LepRs. Moreover, recent evidence suggests hypothalamic neurons are markedly heterogeneous \[[@B29], [@B55]\]. Thus, the authors cannot eliminate the possibility that leptin- and insulin-induced changes in neuronal activity might be obfuscated due to cellular heterogeneity and inherent limitations of targeting responsive cells. An attempt to eliminate such selection biases was made by targeting NPY/AgRP neurons throughout the rostral-caudal axis. Moreover, the acute electrophysiological responses of leptin and insulin were absent in mice deficient for LepR and InsR in AgRP neurons, suggesting that the changes in cellular activity were specific to cognate receptors for leptin and insulin, respectively. Ultimately, these data suggest that endogenously expressed circulating factors, which alter the activity of NPY/AgRP neurons, may have profound effects on metabolism. Moreover, the heterogeneity and distribution of LepRs and InsRs might be important facets in determining the physiological effects of these factors.

4. Conclusion {#s19}
=============

In summary, the current study demonstrates that deficiency of PI3K subunits (p110*α* and p110*β*) in ARC NPY/AgRP neurons impaired energy balance and glucose homeostasis. PI3K catalytic subunits were also required in NPY/AgRP neurons for the acute effects of insulin and leptin on cellular activity. Together, these data provide evidence for PI3K as a substrate for both leptin and insulin to regulate energy balance and glucose metabolism in NPY/AgRP neurons.
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ACSF

:   artificial cerebrospinal fluid

AgRP

:   Agouti-related protein

APT

:   AgRP-cre::p110*α*^fl/fl^::p110*β*^fl/fl^::tdTomato

ARC

:   arcuate

CNQX

:   6-cyano-7-nitroquinoxaline-2,3-dione

hrGFP

:   humanized Renilla green fluorescent protein

InsR

:   insulin receptor

K~ATP~

:   ATP-sensitive K^+^

LepR

:   leptin receptor

NLT

:   NPY-hrGFP::LepR-cre::tdTomato

NPY

:   neuropeptide Y

PI3K

:   phosphoinositide 3-kinase

POMC

:   pro-opiomelanocortin

TTX

:   tetrodotoxin.
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